MYOCARDIAL INFARCTION MARKET ANALYSIS
The global myocardial infarction market is estimated to be valued at US$ 1,816.8 Mn in 2021, and is expected to exhibit a CAGR of 5.9 % over the forecast period (2021-2028).
Figure 1: Global Myocardial Infarction Market Share (%) Analysis, By Drug Class, 2021
The prevalence of heart attack is the major factor that is expected to drive the growth of global myocardial infarction market over the forecast period.
The increasing prevalence of heart attack is expected to drive the growth of global myocardial infarction market. For instance, according to Centers for Disease Control and Prevention report 2019, in the U.S., every year, approximately 805,000 Americans experience heart attack, of these, 605,000 are first-time heart attacks, while 200,000 are repeat heart attacks and one in every five heart attacks is silent.
Research and Development activities
Increasing number of clinical trials for the treatment of castrate-resistant prostate cancer is expected to aid in the growth of the global myocardial infarction market over the forecast period. For instance, in May 2021, Recardio Inc., a clinical-stage life science company focused on regenerative therapies for cardiovascular diseases, completed its Phase 2 randomized, double-blind, placebo-controlled, safety, and efficacy study of dutogliptin in combination with filgrastim in early recovery post-myocardial infarction.
Figure 2: Global Myocardial Infarction Market Value (US$ Mn), by Region, 2021
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
